STAAR Surgical Income After Taxes 2010-2024 | STAA
STAAR Surgical income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
STAAR Surgical Annual Income After Taxes
(Millions of US $) |
| 2023 |
$21 |
| 2022 |
$40 |
| 2021 |
$28 |
| 2020 |
$6 |
| 2019 |
$14 |
| 2018 |
$5 |
| 2017 |
$-2 |
| 2016 |
$-12 |
| 2015 |
$-7 |
| 2014 |
$-8 |
| 2013 |
$0 |
| 2012 |
$-2 |
| 2011 |
$1 |
| 2010 |
$-4 |
| 2009 |
$-7 |
STAAR Surgical Quarterly Income After Taxes
(Millions of US $) |
| 2024-09-30 |
$10 |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$-3 |
| 2023-12-31 |
$8 |
| 2023-09-30 |
$5 |
| 2023-06-30 |
$6 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$7 |
| 2022-09-30 |
$10 |
| 2022-06-30 |
$13 |
| 2022-03-31 |
$10 |
| 2021-12-31 |
$8 |
| 2021-09-30 |
$6 |
| 2021-06-30 |
$9 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$3 |
| 2020-09-30 |
$4 |
| 2020-06-30 |
$-1 |
| 2020-03-31 |
$-0 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$2 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$-0 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-0 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$-8 |
| 2015-12-31 |
$-1 |
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$-2 |
| 2014-12-31 |
$-3 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$-1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$-0 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$0 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-2 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-2 |
| 2009-06-30 |
$-1 |
| 2009-03-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.315B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
